Evidence map›Paper›PMID 33050549›Full record

ReviewInternational journal of molecular sciences2020

Role of CD4

Kento Miura, Kimiko Inoue, Atsuo Ogura, Osamu Kaminuma

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Differential Regulation of Interferon Signaling Pathways in CD4International journal of molecular sciences · 2021
    Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Kento MiuraDepartment of Disease Model, Research Institute of Radiation Biology and Medicine, Hiroshima University, Hiroshima 734-8553, Japan.
Kimiko InoueRIKEN BioResource Research Center, Ibaraki 305-0074, Japan.
Atsuo OguraRIKEN BioResource Research Center, Ibaraki 305-0074, Japan.
Osamu KaminumaDepartment of Disease Model, Research Institute of Radiation Biology and Medicine, Hiroshima University, Hiroshima 734-8553, Japan.ORCID 0000-0003-1211-0410
Hiroshima University · JPRIKEN BioResource Research Center · JP

Funding

Japan Society for the Promotion of Science 15K07787Japan Society for the Promotion of Science 18K19561Japan Society for the Promotion of Science 19H03145Japan Society for the Promotion of Science 19H05758Japan Society for the Promotion of Science JP25112009Joint Research Grant of Research Center for Radiation Disaster Medical Science -Kosé Cosmetology Research Foundation -Mishima Kaiun Memorial Foundation -
6 · The paper itself

Abstract

The essential contribution of CD4

Indexed as

Disease SusceptibilityAnimalsBiomarkersBronchial HyperreactivityCD4-Positive T-LymphocytesCell CommunicationDisease Models, AnimalHumansImmunoglobulin EInflammationMast CellsMiceMice, TransgenicReceptors, Antigen, T-CellSignal TransductionT-Cell Antigen Receptor SpecificityBiomarkersImmunoglobulin EReceptors, Antigen, T-Cellairway inflammationallergyCD4+ T cellsomatic cell nuclear transferT-cell receptor

Identifiers

PMID33050549
PMCPMC7589900
OpenAlexW3092124267

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.